Sun Pharmaceutical Industries submits press release

06 Nov 2019 Evaluate

Sun Pharmaceutical Industries has informed about submission of its press release relating to License Agreement with AstraZeneca for Novel Oncology products in China, which it shall be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1525.00 7.85 (0.52%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.